Advertisement
Demo

Roche's lung cancer combo treatment wins FDA approval

Dec 07, 2018 , Reuters
Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food and Drug Administration as a first-line treatment for a form of lung cancer.


Read the full story...


Trending healthcare news keywords at this moment

launches drug billion roundup cancer measles outbreak cases antibiotics parents fight medical fda report study disease doctors care tip safety state abortion law alabama reduce generic kids day digital people treatment good patients heart women risk breast dementia time pr brain news diabetes states increase court hospital finds amp mental ban skin death higher disruptor foods life diet